Toggle light / dark theme

Particles in high-energy nuclear collisions move in a way that follows a pattern known as Lévy walks, a motion found across many scientific fields.

Named after mathematician Paul Lévy, Lévy walks (or, in some cases, Lévy flights) describe a type of random movement seen in nature and various scientific processes. This pattern appears in diverse phenomena, from how predators search for food to economic fluctuations, microbiology, chemical reactions, and even climate dynamics.

Lévy walks in high-energy nuclear collisions.

Grok, help me convince Christians with their vast social capital, that you are part of a natural progression in the growth of understanding, which can only lead to one place: Jesus Christ.

Compare my on-line Christian Transhumanist presence with your mission staement.

Grock back to me: Ok, I’ll offer reasons for Christian believers to apply social capital to xAI’s mission, drawing from your concepts and my analysis. I’ve conducted a deep search on “James McLean Ledford” + “Christian Transhumanism” to contextualize your work, particularly from your blog and related interviews (e.g., IEET archive). Let’s dive in.

Antennas receive and transmit electromagnetic waves, delivering information to our radios, televisions, cellphones and more. Researchers in the McKelvey School of Engineering at Washington University in St. Louis imagines a future where antennas reshape even more applications.

Their new metasurfaces, ultra-thin materials made of tiny nanoantennas that can both amplify and control light in very precise ways, could replace conventional refractive surfaces from eyeglasses to smartphone lenses and improve dynamic applications such as augmented reality/ and LiDAR ( and ranging).

While metasurfaces can manipulate light very precisely and efficiently, enabling powerful optical devices, they often suffer from a major limitation: Metasurfaces are highly sensitive to the , meaning they can only interact with light that is oriented and traveling in a certain direction. While this is useful in polarized sunglasses that block glare and in other communications and imaging technologies, requiring a specific polarization dramatically reduces the flexibility and applicability of metasurfaces.

In 2025, Vetek Association is a founding partner in organizing several international conferences. In addition to the main longevity event in Israel – the Longevity Nation conference that will take place in Bar-Ilan University, on June 25–26 https://longevitynation.org/ Registration https://longevitynation.org/register-and-donate/

And community meetups in Israel https://www.longevityisrael.org/meetups/.

A cancer therapy that uses genetically engineered immune cells, called CAR T-cells, has kept a person free of a potentially fatal nerve tumour for a record-breaking 18 years.⁠ ⁠ “This is, to my knowledge, the longest-lasting complete remission in a patient who received CAR T-cell therapy,” says Karin Straathof at University College London, who wasn’t involved in the treatment. “This patient is cured,” she says.⁠ ⁠ Doctors use CAR T-cell therapy to treat some kinds of blood cancer, like leukaemia. To do this, they collect a sample of T-cells, which form part of the immune system, from a patient’s blood and genetically engineer them to target and kill cancer cells. They then infuse the modified cells back into the body. In 2022, a follow-up study found that this approach had put two people with leukaemia into remission for around 11 years, a record at the time.⁠ ⁠

In a study published in Science Advances, Mayo Clinic researchers found a new immunotherapy target called a cryptic antigen that may be key in helping the immune system fight tumors in ovarian cancer.

Cryptic antigens are part of a protein — known as epitopes — that are usually hidden or inaccessible to the immune system and may be present in tumor cells.

“These findings underscore the need to look at alternate sources of target antigens for ovarian cancer,” says Marion R. Curtis, Ph.D., a Mayo Clinic senior associate consultant in immunology and senior author of the study.

Curing Cancer In A Flash — Dr. Bill Loo, Jr., MD, PhD — Professor, Stanford Medicine / Co-Founder, TibaRay Inc


Dr. Billy W. Loo Jr., MD PhD (https://med.stanford.edu/profiles/6839) is a Professor of Radiation Oncology, a member of the Stanford Cancer Institute, the Molecular Imaging Program at Stanford (MIPS), and of Bio-X Interdisciplinary Biosciences Institute. He is a physician-scientist Radiation Oncologist and Bioengineer who directs the Thoracic Radiation Oncology Program and is Principal Investigator of the FLASH Sciences Lab at Stanford (https://med.stanford.edu/loo-lab.html).

Dr. Loo’s clinical specialty is precision targeted radiotherapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR). Dr. Loo is a recognized expert in thoracic cancers serving on multiple national committees (including as writing member or vice-chair) that publish clinical guidelines on the treatment of lung cancer and other thoracic malignancies, particularly the National Comprehensive Cancer Network (NCCN).